20xx年醫(yī)學(xué)專題—急性冠脈綜合征評(píng)估及危險(xiǎn)分層(文件)
【正文】 899. (with permission) Varo N, et al. Circulation. 2003。,Clopidogrel, but not ASA, Reduces ADPInduced Expression of CD40L,Hermann A, et al. Platelets. 2001。,Vascular Damage,Inflammation,Myocyte Necrosis,Accelerated Atherosclerosis,Hemodynamic Stress,HbA1c Blood glucose,CrCl Microalbuminuria,Troponin,BNP, NTproBNP,hsCRP, CD40L,Morrow DA, et al. Circulation. 2003。ng)總結(jié),Acute Coronary Syndromes Evaluation and Risk Stratification。CRP 10mg/l (n=309)。825 565 1133,第二十二頁(yè)，共二十二頁(yè)。Chi Square: P=.0007。No. Studies: 13 6。,內(nèi)容(n232。,Effect of Treatment with Abciximab According to the Levels of Troponin T and Soluble CD40 Ligand,Heeschen C, et al. N Eng J Med. 2003。,Soluble CD40L in ACS,Heeschen C, et al. N Engl J Med. 2003。105:17601763. (with permission),P=.014,P=.001,67,150,155,78,504,717,324,90,30 Day Mortality (%),30Day Mortality Rel Risk,第十六頁(yè)，共二十二頁(yè)。345:10141021. (with permission),第十四頁(yè)，共二十二頁(yè)。31:14601465.,第十二頁(yè)，共二十二頁(yè)。g/l (n=377),Troponin T 0.600.59 181。,TIMI IIIB: Troponin I Levels Predict Mortality In UA/NSTEMI,1.0,1.7,3.4,3.7,6.0,7.5,0,2,4,6,8,0 to 0.4,0.4 to 1.0,1.0 to 2.0,2.0 to 5.0,5.0 to 9.0,9.0,831,174,148,134,67,50,Risk Cardiac Troponin I (ng/ml) Ratio 1.0 1.8 3.5 3.
環(huán)評(píng)公示相關(guān)推薦
鄂ICP備17016276號(hào)-1